Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisco J Cimas

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Aging|March 16, 2016
MKP1: Jekyll and Hyde for E1AFrancisco J Cimas, Juan Callejas-Valera Luis Callejas-Valera, Ricardo Sanchez-Prieto
International Journal of Molecular Sciences|August 23, 2020
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer TreatmentAlberto Juan, Francisco J Cimas, Iván Bravo, et al.
Pharmaceutics|August 29, 2020
An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer TherapyAlberto Juan, Francisco J Cimas, Iván Bravo, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2016
Hepatitis C Virus RNA-Dependent RNA Polymerase Interacts with the Akt/PKB Kinase and Induces Its Subcellular RelocalizationMaría Llanos Valero, Rosario Sabariegos, Francisco J Cimas, et al.
Frontiers in Cell and Developmental Biology|July 23, 2016
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the StoryJesús García-Cano, Olga Roche, Francisco J Cimas, et al.
Antioxidants (Basel, Switzerland)|June 28, 2023
Effect of Crocetin on Basal Lipolysis in 3T3-L1 AdipocytesFrancisco J Cimas, Miguel Ángel De la Cruz-Morcillo, Carmen Cifuentes, et al.
Pharmaceutics|October 22, 2020
Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast CancerFrancisco J Cimas, Enrique Niza, Alberto Juan, et al.
Cancers|August 16, 2020
Genomic Mapping Identifies Mutations in RYR2 and AHNAK as Associated with Favorable Outcome in Basal-Like Breast Tumors Expressing PD1/PD-L1Francisco J Cimas, Arancha Manzano, Mariona Baliu-Piqué, et al.
BMC Research Notes|November 13, 2025
Specific transcriptional signature dataset of extracellular signal-regulated kinase 5 in leiomyosarcoma derived cell linesJaime Jiménez-Suárez, Cristina Garnés-García, Pablo Fernández-Aroca, et al.
Urologic Oncology|November 13, 2016
Implication of VHL, ERK5, and HIF-1alpha in clear cell renal cell carcinoma: Molecular basisLeticia Serrano-Oviedo, José M Giménez-Bachs, Syongh Y Nam-Cha, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Aging|March 16, 2016
MKP1: Jekyll and Hyde for E1AFrancisco J Cimas, Juan Callejas-Valera Luis Callejas-Valera, Ricardo Sanchez-Prieto
International Journal of Molecular Sciences|August 23, 2020
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer TreatmentAlberto Juan, Francisco J Cimas, Iván Bravo, et al.
Pharmaceutics|August 29, 2020
An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer TherapyAlberto Juan, Francisco J Cimas, Iván Bravo, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2016
Hepatitis C Virus RNA-Dependent RNA Polymerase Interacts with the Akt/PKB Kinase and Induces Its Subcellular RelocalizationMaría Llanos Valero, Rosario Sabariegos, Francisco J Cimas, et al.
Frontiers in Cell and Developmental Biology|July 23, 2016
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the StoryJesús García-Cano, Olga Roche, Francisco J Cimas, et al.
Antioxidants (Basel, Switzerland)|June 28, 2023
Effect of Crocetin on Basal Lipolysis in 3T3-L1 AdipocytesFrancisco J Cimas, Miguel Ángel De la Cruz-Morcillo, Carmen Cifuentes, et al.
Pharmaceutics|October 22, 2020
Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast CancerFrancisco J Cimas, Enrique Niza, Alberto Juan, et al.
Cancers|August 16, 2020
Genomic Mapping Identifies Mutations in RYR2 and AHNAK as Associated with Favorable Outcome in Basal-Like Breast Tumors Expressing PD1/PD-L1Francisco J Cimas, Arancha Manzano, Mariona Baliu-Piqué, et al.
BMC Research Notes|November 13, 2025
Specific transcriptional signature dataset of extracellular signal-regulated kinase 5 in leiomyosarcoma derived cell linesJaime Jiménez-Suárez, Cristina Garnés-García, Pablo Fernández-Aroca, et al.
Urologic Oncology|November 13, 2016
Implication of VHL, ERK5, and HIF-1alpha in clear cell renal cell carcinoma: Molecular basisLeticia Serrano-Oviedo, José M Giménez-Bachs, Syongh Y Nam-Cha, et al.
Pageof 3